Zota Health Care LImited has informed the Exchange regarding allotment of 795000 equity shares pursuant to Preferential Issue by way of circular resolution passed on April 17, 2025.

Fund Raising View source PDF Explain this filing

ZOTA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.6%Reaction day

₹881.75

prior close

₹891.75

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+1.5%-0.9% vs market

Pharmaceuticals peers, median of 148sector+0.7%-0.2% vs sector

On the reaction day the stock moved 0.9 pts less than Nifty Microcap 250 and 0.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.2

10m

-1.4

15m

-1.7

30m

-2.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.6+1.5-0.9+0.7-0.2

Next day

-0.6+2.4-3.0+0.9-1.5

-1.9+2.4-4.3+1.6-3.5

+0.6+2.8-2.2+2.8-2.2

-4.2+0.1-4.2-0.7-3.4

-3.6+0.0-3.6-0.8-2.8

-2.5-2.3-0.2-2.5+0.1

15d

+6.8+2.9+3.9-0.2+7.0

+13.6+7.4+6.2+2.5+11.1

+5.4+8.7-3.3+0.5+4.9

+35.9+14.6+21.3+7.5+28.4

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 148Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Zota Health Care Limited has allotted 795,000 equity shares pursuant to a Preferential Issue. The allotment was approved via a circular resolution passed on April 17, 2025. The company has informed the stock exchange about this development. No details about the issue price, investors, or use of proceeds were mentioned in the announcement.

Likely market impact

The preferential allotment will lead to dilution of existing shareholders' equity stake. Without details on the issue price and use of funds, the precise impact on the stock or shareholders cannot be determined from this filing alone.